Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale).

Organisations Organisation Probiodrug AG (Euronext Amsterdam: PBD)
  Today Vivoryon Therapeutics AG (Euronext Amsterdam: VVY)
  Group Vivoryon (Group)
  Organisation 2 Nordic Bioscience A/S
  Today Nordic Bioscience (Group)
  Group CCBR (Group)
Products Product PQ912 (Probiodrug)
  Product 2 investment banking
Index term Index term Probiodrug–SEVERAL: investment, 201904 private placement €8.2m net €7.65m with 4.1m new shares at €2m led by Claus Christiansen et al.
Persons Person Christiansen, Claus (CCBR + Nordic Bioscience Founder + Chairman)
  Person 2 Dauer, Ulrich (Probiodrug 201805– CEO before Omeicos + Activaero + 4SC + Tripos)
     


   
Record changed: 2019-04-16

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Vivoryon (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top